ReviewFrontiers in medicine2026
Contrast-enhanced ultrasound in critical care: a problem-solving approach.
Review in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
When the body enters a rapidly progressive and life-threatening pathological state, it is defined as critical illness. At this stage, respiratory and circulatory dysfunction are the most prevalent clinical manifestations. During disease progression and therapeutic interventions, persistent pathological insults, sustained microcirculatory hypoperfusion, and systemic inflammatory responses further contribute to complications such as coagulopathy, acute kidney injury, gastrointestinal dysfunction, and ICU-acquired weakness. Contrast-enhanced ultrasound (CEUS), as a non-invasive and bedside-applicable imaging modality, enables sensitive detection of tissue-level perfusion changes and provides crucial insights for the early identification of organ dysfunction and disease progression. Based on recent advances and our clinical experience, this article focuses on the evaluation and interventional strategies for perfusion-related pathophysiological processes in vulnerable organs within the ICU setting. In particular, we highlight the value of CEUS in assessing hemodynamics in the kidney, gastrointestinal tract, and skeletal muscle, emphasizing its role in microcirculatory monitoring, early disease recognition, CEUS-guided percutaneous interventions, and optimization of thrombus-related therapeutic decision-making. Collectively, these applications could support more precise interventions and have potential to improved patient outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.